Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-007404

Chief Accounting Officer sold 901 shares at $0.67 ($604)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-23 Sale : show line 1 in the form −901 $0.67 $604 96,289 D
Open-market sales · 901 sh · avg $0.67 · $604
Loading xslF345X05/ownership.xml…